ENFINIT PLATFORM FOR CAR-T

Live / Applied — Suspended — suspension check completed, case still suspended (as of 24 Dec 2025)

What this means for you

Not registered yet, but its 14 Sept 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79330693
Mark type
Stylized text
Filed
14 Sept 2021
Attorney of record
Jill Anderfuren

Goods and services

  • Class 001 — Chemicals: Biological and chemical preparations for use in the pharmaceutical industry and research; chemical reagents for the manufacture of therapeutic immunotherapy solutions
  • Class 005 — Pharmaceuticals: Pharmaceutical products for use in the fields of oncology and immunotherapy; biological and pharmaceutical preparations for treatment of cancer and tumors; biological and pharmaceutical preparations for treating cancer and tumors using immunotherapy; preparing therapeutic preparations being solutions, namely, antigen, antibodies, T-cells in the nature of preparations for treatment of cancer and tumors; biological materials, preparations, reagents being pharmaceutical for products for medical use in the treatment of cancer and tumors; pharmaceutical antigens, antibodies, and cells for therapeutic use
  • Class 040 — Treatment of materials: Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; custom manufacturing of antigens, antibodies, T-cells; Providing medical information relating to immunotherapy; information, advice and consulting services related to the field of pharmaceutical products manufacturing
  • Class 042 — Scientific and technological services: Scientific research services, namely medical research; scientific research and product development, namely, identifying, screening and developing antigens; scientific and technological services, namely, scientific research, analysis and testing in the field of oncology and immunotherapy; scientific laboratory services; providing scientific and medical research information on immunotherapy; providing scientific research services for identifying, analyzing, authenticating, purifying and developing biological material from a genomic platform; scientific analysis, namely, epigenetic antigen screening and identification services for therapeutic research purposes; scientific research, namely, genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; designing algorithms and models for use in scientific and medical research; providing temporary use of online non-downloadable computer software platforms enabling the use of algorithms for analyzing cells, antigens, tissue, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; providing temporary use of online non-downloadable computer software platforms enabling the use of algorithms for forecasting the characteristics of antigens and immunological responses
  • Class 044 — Medical, beauty and agricultural services: Providing medical information relating to immunotherapy

Owner

Prosecution history

  • 24 Dec 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
  • 23 Jun 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
  • 18 Jun 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
  • 17 Dec 2024 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
  • 16 Dec 2024 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
  • 17 Aug 2024 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
  • 31 Jul 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
  • 31 Jul 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
  • 09 Jan 2024 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
  • 12 Jul 2023 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
  • 11 Apr 2023 — ATTORNEY REVIEW COMPLETED
  • 11 Apr 2023 — CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
  • 05 Mar 2023 — USPTO CORRECTION PROCESSED BY IB
  • 05 Mar 2023 — USPTO CORRECTION PROCESSED BY IB
  • 05 Mar 2023 — CORRECTION TRANSACTION RECEIVED FROM IB

View this trademark record on Marksy